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Objectives: The aim of the present study was to assess the short term prognostic signifi-
cance of N-terminal pro BNP (NT-proBNP), 3D left atrial volume (LAV) and left ventricular
(LV) dyssynchrony in patients of acute ST-elevation myocardial infarction (STEMI) who
underwent primary Percutaneous intervention (PCI).
Background: NT-proBNP, LV dyssynchrony and LAV in patients with acute coronary syn-
drome have been associated with PCI outcomes and predict the short and long-term
prognosis.
Methods: This study consisted of 142 patients with a first STEMI who underwent primary
PCI. Baseline echocardiographic data was collected at admission and at 6 months follow
up. Left ventricular dyssynchrony was measured by tissue Doppler imaging and LAV by
real time 3D-echocardiography, plasma NT-proBNP levels were estimated between 72 and
96 h of admission.
Results: During study period 3 patients expired and 4 developed congestive heart failure
(CHF). Baseline NT-proBNP and LV dyssynchrony correlated with LV size and LV ejection
fraction (LVEF) at baseline and during follow up. Patients with higher NT-proBNP levels and
higher LV dyssynchrony showed significant increase in LV size with decrease in LVEF
during follow-up. Baseline Left atrial volume index (LAVI) showed significant correlation
with LV size but no association with LVEF at baseline and during follow-up.
Conclusions: Higher levels of NT-proBNP and higher LV dyssynchrony can predict patients
with increase in LV size, worsening of LV systolic and diastolic function during follow-up.
Patients with higher NT-proBNP levels at baseline developed CHF during follow-up.
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There is a world wide epidemic of coronary heart disease
(CHD) and ST-elevation acutemyocardial infarction (STEMI) is
one of themost lethal form of acute coronary syndrome (ACS).
Primary Percutaneous Coronary Intervention (PCI) has been
shown to reduce death, reinfarction, stroke and hemorrhagic
stroke in patients with STEMI.1
After acutemyocardial infarction (AMI) left ventricular (LV)
remodeling occurs in up to 25% of patients2,3 and is a detri-
mental complication characterized by dilatation of heart
chambers, change in chamber geometry and progressive
deterioration of LV function. Remodeling is directly related
with development of heart failure and poor prognosis.4,5
N-terminal pro brain natriuretic peptide (NT-proBNP) is
secreted predominantly from the ventricles, and its levels in
plasma have been shown to be increased after AMI and
associatedwith LV systolic dysfunction.6 In previous studies it
was suggested that elevated NT-proBNP is associated with
development of heart failure (HF) and mortality after AMI.7e9
In patients with AMI, plasma NT-proBNP levels estimated
2e4 days after its development independently predicted LV
ejection fraction (LVEF) and 2 years survival.9
Regardless of QRS width ACS has significant impact on LV
dyssynchrony and this has been shown to have detrimental
effects on the systolic function of LV.10 In patients with
impaired LV function, dyssynchrony predicts LV remodeling11
and long-term outcome.12 For the first time Zhang et al13
demonstrated that infract size was the main determinant of
LV dyssynchrony after AMI. Later Mollema et al14 in their
study showed that LV dyssynchrony in patients with STEMIFig. 1 e Image showing LA volumeindependently predicted LV remodeling at 6 months. Left
atrial volume (LAV) is an independent predictor of adverse late
outcome in patients with AMI and prior MI. Left atrial volume
is superior to conventional Doppler indices of diastolic func-
tion in predicting long-term outcomes after AMI.15
The present study was done to assess the short-term
prognostic significance of NT-proBNP, LV dyssynchrony and
left atrial volume index (LAVI) in patients with AMI undergo-
ing primary PCI.2. Methods
2.1. Study population
A total of 142 patients who were diagnosed with a first STEMI,
defined as characteristic chest pain lasting for more than
20 min, typical ST segment elevation >1 mm in at least two
contiguous leads associated with transient rise of creatine
kinase MB or troponin and who underwent primary PCI, from
May 2012 to February 2013were enrolled after taking informed
written consent. Institutional ethics committee approval was
obtained prior to initiation of the study. These patients were
followed for a period of 6 months and at the time of follow up,
data was collected pertaining to current clinical status, prior
hospitalization and occurrence of any of the adverse events.
Patients above 80 years of age, with previous history of MI,
coronary bypass surgery, angioplasty, presence of valvular
heart disease, with non-sinus rhythm, with pre-existing
bundle branch block, with renal failure and echocardio-
graphic images of poor quality were excluded from the study.by RT3DE in a study patient.
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N-terminal-proBNP levels were measured by using Roche
CARDIAC proBNP test kit (code 04659449190, Roche Di-
agnostics Ltd. Germany) and cobas h 232 POC (Point Of Care)
system. About 2 mL of blood sample for NT-proBNP levels was
collected by venipuncture into heparinized tubes between 72
and 96 h after primary PCI. The reaction times for the assay
were between approximately 10 and 15 min, the sample vol-
umes needed were 150 mL of heparinized venous whole blood.
Detection range of the assay is 60e9000 pg/mL of NT-proBNP.2.3. Echocardiographic data
Transthoracic M mode, 2-dimensional, and Doppler echocar-
diography data were recorded for all the patients within 48 h
of primary PCI and after 6 months of procedure using a Philips
IE-33 machine, Holland. Parameters included were LVEF (%),
LV end-systolic diameter (LVESD) (mm), LV end-diastolic
diameter (LVEDD) (mm), MV peak E-wave velocity (cm/s), MV
peak A-wave velocity (cm/s), MV peak E/A ratio and E/E0 ratio.
Mitral inflow was assessed from the apical four-chamber
view with pulsed-wave Doppler and the beam was aligned
parallel to the direction of flow and a 1e2 mm sample volume
was placed between the tips of mitral leaflets during dias-
tole.16 From the mitral inflow profile, the E- and A-wave ve-
locity, and E/A velocity ratio wasmeasured. Diastolic function
was categorized as normal function (E0 10 or E/E0 8), mild
dysfunction (E0 <8 and E/E0 <8), moderate dysfunction (E0< 8
and E/E0 9e14) and severe dysfunction (E0 <5 or E/E0 15).17e19
Patients were classified as having normal LV systolic function
when LVEF is >50%, mild LV systolic disfunction when LVEF
was 41e49%, moderate LV systolic dysfunction when LVEF
was 35e40% and severe LV systolic dysfunction when LVEF
was below 35%.2.4. Left atrial volume assessment by real-time 3-
dimensional echocardiography
Using a Real-time 3D (RT3D) matrix array transducer LAV was
collected in four-cycles full volumemade during a breath hold
within 48 h of AMI and zoom function gain adjustments was
used to clearly define the endocardial border. This 3D dataset
was transferred to a Q-LAB system for offline analysis. Left
atrial volume was calculated by a semiautomated tracing of
the LA endocardial border by marking five atrial points: the
anterior, inferior, lateral, septalmitral annuli and the LA apex.
When necessary modifications were made to correct auto-
matic tracings (Fig. 1).20 The obtained 3D LAV was indexed to
body surface area.2.5. Left ventricular dyssynchrony assessment by tissue
Doppler imaging
In the left lateral decubitus position, the 2D colour-Tissue
Doppler imaging (TDI) cine loops of multiple beats were
stored digitally for off line analysis.21,221. The ‘‘Depth’’ option was adjusted so that the acquired loop
includes only the LV from the apex down to level of the
mitral valve annulus.
2. The ‘‘Angle’’ option was adjusted to clearly visualize the
opposing LV walls with the narrowest possible sector.
3. Maximum available frame rate was set for the corre-
sponding sector width.
From each of the apical 4-chamber, apical 2-chamber and
apical long-axis views color coded TDI loops were obtained.
Time velocity plots were determined by placing region of in-
terests (ROI) in the basal and mid segments of opposing LV
walls. For each view 4 regions were selected excluding the
apical segments (4 regions/view). From the beginning of the
QRS complex to the peak myocardial systolic velocity during
the ejection phase was taken as Time to peak systolic velocity
(Ts) and thus we calculated the Ts for 12 segments and the LV
dyssynchrony was measured as the difference between the
maximum and minimal Ts among these 12 segments
(Fig. 2).11,23
2.6. Statistical analysis
Data was tabulated on MS-Excel 2007 spreadsheets (Microsoft
Corporation, Redmond, WA, USA). Descriptive statistics for
the categorical variables were performed by computing the
frequencies (percentage) in each category. For the quantitative
variables, mean and standard deviation were calculated.
Independent Student's ‘t’-test and ANOVA tests were per-
formed to test the significant differences of means wherever
appropriate. Pearson's correlation test was performed to find
out the relationship between various parameters. Multivariate
analysis was performed to test the association of different
independent variables with dependent variable. A p-value
0.05 was considered as significant p-value. Statistical soft-
ware package SPSS 20 (IBM corporation, Chicago, IL, USA) was
used for statistical analysis.3. Results
The study group consisted of 142 patients (123 men and mean
age was 53.30 ± 11.88 years). The mean time from onset of
symptoms to presentation was 6.33 h (±3.60 h). Majority of the
study patients presented with Killips class-I (78.2%). Anterior
wall MI was present in 57.7% of patients (Table 1).
At baseline, mean NT-proBNP levels in these patients were
1616.82 pg/mL. Because of wide variation in the levels of NT-
proBNP in the study group (range 60e9000), log trans-
formation was done for NT-proBNP levels. After log trans-
formation mean log NT-proBNP levels was 6.97 (±0.91) (Table
1).
Left Anterior Descending (LAD) artery was the culprit
vessel in 54.9%, Left Circumflex (LCx) artery in 11.3%, Right
Coronary artery (RCA) in 33.8% of the patients. Multi-vessel
disease was present in 34.5% of patients. Total occlusion of
culprit vessel was present in 68.3% whereas 31.7% of patients
showed subtotal occlusion. Thrombus aspiration was done in
27.5% of patients. Drug eluting stents (DES) were deployed in
83.1% and bare metal stents (BMS) in 13.4% of patients.Only
Fig. 2 e Image showing assessment of LV dyssynchrony by TDI.
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(POBA). Glycoprotein (GP) 2b/3a inhibitors were used in 87.3%
of patients (Table 1).
Mean LVEDD and LVESD of the study populationwere 46.81
(±4.59) mm and 34.15 (±4.74) mm respectively. Mean LVEFwas
50.84 (±8.30)%. Mean E0 and E/E0 were 6.40 (±1.56) cm/sec and
11.72 (±3.40) respectively. Mean left ventricular end diastolic
diameter index (LVEDDI) and left ventricular end systolic
diameter index (LVESDI) were 28.97 mm/m2 (±8.50) and
21.2 mm/m2 (±7.01) respectively. Mean LV dyssynchrony of
the study population was 55.79 (±14.93 ms). Mean LAVI in
these patients was 17.71 mL/m2 (±4.41) (Table 2).
After six months mean LVEDD has increased from
46.81 mm to 49.62 mm which was statistically significant
(p < 0.001) whereas there was no significant change in LVESD
(34.15 mme34.78 mm, p ¼ 0.129) compared to baseline. There
was significant improvement in LVEF after six months of
follow up period (50.84%e54.73%, p < 0.001). During follow-up
if change in LVEDD and LVESD was more than 10% of the
baseline, it was considered significant and accordingly pa-
tients were categorized into two groups. Similarly more than
10% change in baseline LVEF either way was considered
significant.
Three patients were lost to follow up after discharge.
During follow up, 3 deaths were observed in the study popu-
lation. Two patients developed sudden cardiac death within
the first month of the index procedure. Only 4 patients
developed congestive heart failure (CHF) during the studyperiod. Among them one patient developed CHF with NYHA
class-IV dyspnea within the first month of the index proce-
dure and expired during the hospital stay with severe LV
systolic dysfunction. Another patient developed CHF during
index hospitalization, recovered and was lost to follow up
after discharge. Two more patients developed CHF within the
six months of index procedure improved with hospitalization
and increase in dosage of diuretics.
3.1. Log NT-proBNP levels
Age, window period, Killips class at presentation showed
significant positive correlation with log NT-proBNP levels.
Female patients had significantly higher levels compared to
males (p ¼ 0.022). Smokers had significantly lower levels
compared to non-smokers (p ¼ 0.034). Type of MI, hyperten-
sion and diabetes did not significantly influence log NT-
proBNP levels. The levels were significantly higher in pa-
tients with multi-vessel disease (p ¼ 0.004) and with total oc-
clusion of culprit vessel (p ¼ 0.019) (Table 2).
Log NT-proBNP levels had significant positive correlation
with baseline LVESD, LVEDDI, LVESDI, E/E0, LAVI, LV dyssyn-
chrony and negative correlation with E0 (Table 3). The levels
had significant positive correlation with follow-up LVEDD,
LVESD and negative correlation with LVEF both at baseline
and follow-up (Table 4). Patientswith higher NT-proBNP levels
had significant increased in LVESD with decrease in LVEF
during follow-up (Table 4).
Table 1 e Demographics and PCI data.
Characteristic (n ¼ 142) Mean ± SD/n (%)
Age (years) 53.30 ± 11.88
Gender:
Male 123 (86.6%)
Female 19 (13.4%)
Type of MI:
AWMI 82 (57.7%)
Non-AWMI 60 (42.3%)
KILLIPS Class:
Class-I 111 (78.2%)
Class-II 19 (13.4%)
Class-III 4 (2.8%)
Class-IV 8 (5.6%)
Hypertension:
Hypertensives 56 (39.4%)
Non-hypertensives 86 (60.6%)
Diabetes mellitus:
Diabetics 51 (35.9%)
Non-diabetics 91 (64.1%)
Tobacco consumption:
Yes 93 (65.5%)
No 49 (34.5%)
Window period (hours) 6.33 ± 3.60
NT-proBNP (pg/mL) 1616.82 ± 1737.24
log NT-proBNP 6.97 ± 0.91
IRCA:
LAD 78 (54.9%)
LCX 16 (11.3%)
RCA 48 (33.8%)
No. of vessels involved:
SVD 93 (65.5%)
2VD & TVD 49 (34.5%)
Type of Obstruction:
Total occlusion 97 (68.3%)
Subtotal occlusion 45 (31.7%)
Thrombus aspiration:
Done 39 (27.5%)
Not done 103 (72.5%)
Type of Stent:
DES 118 (83.1%)
BMS 19 (13.4%)
POBA 5 (3.5%)
No. of Stents:
No Stent 5 (3.5%)
1 Stent 107 (75.4%)
2 Stents 29 (20.4%)
3 Stents 1 (0.7%)
GP 2b/3a inhibitors:
Given 124 (87.3%)
Not given 18 (12.7%)
AWMI: anterior wall myocardial infarction; NT-proBNP: N-terminal
pro B-type natriuretic peptide; LAD: left anterior descending artery;
LCX: left circumflex artery; RCA: right coronary artery; SVD: single
vessel disease; 2VD: two vessel disease; TVD: triple vessel disease;
DES: drug eluting stent; BMS: bare-metal stent; POBA: plain old
balloon angioplasty.
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Patients with anterior wall MI had significantly higher LV
dyssynchrony. Higher LV dyssynchrony was found in patients
with higher Killips class at presentation. There was significant
positive correlation with log NT-proBNP levels. (Table 2)Patientswith culprit lesion in RCAhad lesser LV dyssynchrony
compared to LAD and LCX (p ¼ 0.002), but there was no sig-
nificant difference between patients with culprit lesions in
LAD and LCX (Table 2).
LV dyssynchrony had significant positive correlation with
LVESD, LAVI, LVEDDI, LVESDI and negative correlation with
LVEF at baseline.(Table 3) It also had positive correlation with
LVEDD, LVESD and negative correlation with LVEF at follow-
up (Table 4). Higher baseline LV dyssynchrony was found in
patients who had significant increase in LVEDD, LVSED
compared to those who had no significant increase in LV di-
ameters and also in patients with significant decrease in LVEF
at follow-up (Table 4).
3.3. Left atrial volume index
LAVI was significantly lower in diabetic patients (p ¼ 0.031)
and there was significant positive correlation with basal log
NT-proBNP levels (p ¼ 0.041).Significantly higher LAVI was
seen in patients with total occlusion of the culprit vessel
(Table 2). LAVI had significant positive correlation with base-
line LVEDD, LVESD, E velocity, E/E0, E/A ratio, LVEDDI, LVESDI
and LV dyssynchrony (Table 3). In the study group LAVI had
significant positive correlation with follow up LVEDD, LVESD.
There was no significant difference in LAVI between the pa-
tients who had significant change in LVEDD, LVSED, LVEF
compared to those who had no significant change (Table 4).
Fig. 3 showing comparison of NT-proBNP, LA volume and
LV dyssynchrony in patients with increase in LVEDD and no
change in LVEDD.
Binary logistic regression analysis was done for predictors
of significant increase in LVESD after six months of primary
PCI. It showed that LV dyssynchrony (ODDS ratio: 0.942,
p¼ 0.004), LVEDDI (ODDS ratio: 0.498, p¼ 0.007), LVESDI (ODDS
ratio: 2.439, p ¼ 0.011), log NT-pro BNP (ODDS ratio: 0.457,
p ¼ 0.013) were the independent predictors of significant in-
crease in LVESD during follow up. Binary logistic regression
analysis was done for predictors of significant decrease in
LVEF after six months of primary PCI. It showed that only log
NT-proBNP (ODDS ratio: 0.320, p ¼ 0.013) as an independent
predictor for decrease in LVEF during follow up (Table 5).4. Discussion
Primary PCI has been implemented in routine daily practice as
the preferred reperfusion therapy in patients with STEMI and
early detection of LV remodeling is an important task, as it is a
detrimental complication in these patients.4,5,24,25
4.1. NT-proBNP in Primary PCI
The diagnostic and prognostic role of plasma NT-proBNP
levels in patients with LV systolic and diastolic dysfunction
has been extensively studied. In this prospective study we
assessed the prognostic significance of plasma NT-proBNP
levels in patients with AMI.
Talwar et al26 in their study observed that plasma NT-
proBNP levels assessed between 72 and 120 h following AMI
better predicted LV systolic dysfunction and poor out comes
Table 2 e Relationship of demographics and PCI data with study parameters on Univariate analysis.
Log BNP levels LV dyssynchrony LAVI
Mean ± SD or r-value p-value Mean ± SD or r-value p-value Mean ± SD or r-value p-value
Age (years) 0.348 <0.0001** 0.131 0.121 0.152 0.071
Gender:
Male 6.90 ± 0.91 0.022* 55.31 ± 14.69 0.332 17.84 ± 4.44 0.349
Female 7.41 ± 0.79 58.89 ± 16.50 16.82 ± 4.22
Type of MI:
AWMI 7.06 ± 1.01 0.164 59.59 ± 16.19 <0.001** 17.16 ± 4.26 0.088
Non-AWMI 6.85 ± 0.74 50.58 ± 11.21 18.45 ± 4.55
KILLIPS Class:
Class-I 6.81 ± 0.79 <0.0001** 54.11 ± 12.59 0.035* 17.50 ± 4.24 0.395
Class-II 7.46 ± 1.13 60.84 ± 21.58 17.89 ± 4.65
Class-III&IV 7.69 ± 0.99 63.33 ± 19.44 19.32 ± 5.58
Hypertension:
Hypertensives 6.96 ± 0.96 0.924 55.61 ± 17.21 0.907 18.51 ± 5.13 0.079
Non-hypertensives 6.97 ± 0.88 55.91 ± 13.35 17.18 ± 3.82
Diabetes mellitus:
Diabetics 6.79 ± 1.03 0.072 53.61 ± 13.18 0.194 16.65 ± 3.82 0.031*
Non-diabetics 7.07 ± 0.82 57.01 ± 15.78 18.30 ± 4.63
Tobacco consumption:
Yes 6.85 ± 0.90 0.034* 54.56 ± 12.07 0.178 17.35 ± 4.13 0.186
No 7.19 ± 0.88 58.12 ± 19.18 18.38 ± 4.88
Window period (hours) 0.262 0.002** 0.151 0.072 0.005 0.956
IRCA:
LAD 7.07 ± 1.01 0.346 59.24 ± 16.04 0.002* 17.16 ± 4.29 0.258
LCX 6.93 ± 0.67 56.81 ± 15.87 18.25 ± 5.59
RCA 6.83 ± 0.79 49.83 ± 10.54 18.42 ± 4.14
No. of vessels involved:
SVD 6.81 ± 0.79 0.004** 54.47 ± 14.77 0.149 17.25 ± 4.06 0.086
2VD & TVD 7.27 ± 1.04 58.28 ± 15.09 18.59 ± 4.95
Type of Obstruction:
Total occlusion 7.09 ± 0.83 0.019** 57.00 ± 15.84 0.157 18.32 ± 4.54 0.014**
Subtotal occlusion 6.71 ± 1.01 53.18 ± 12.55 16.38 ± 3.85
Thrombus aspiration:
Done 6.81 ± 0.67 0.193 54.67 ± 12.05 0.584 17.63 ± 4.37 0.898
Not done 7.03 ± 0.98 56.21 ± 15.93 17.74 ± 4.45
log NTproBNP e e 0.473 <0.0001** 0.72 0.041*
AWMI: anterior wall myocardial infarction; IRCA: infarct related coronary artery; LAD: left anterior descending artery; LCX: left circumflex
artery; RCA: right coronary artery; SVD: single vessel disease; 2VD: two vessel disease; TVD: triple vessel disease; BNP: B-type natriuretic peptide.
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levels between 72 and 96 h following AMI.
We observed higher NT-proBNP levels in elderly patients,
those patients with longer window period and higher Killips
class at presentation. Contrary to that observed by Talwar
et al26 there was no significant difference in plasma NT-
proBNP levels between anterior wall MI and non anterior
wall MI patients in our study. Patients with multi vessel dis-
ease and total occlusion of infarct related coronary artery had
higher NT-proBNP levels compared to those with single vessel
disease and subtotal occlusion respectively. This may prob-
ably be due to larger ischemic burden in these patients.
PlasmaNT-proBNP levels were not influenced by thrombus
aspiration, administration of GP 2b/3a inhibitors and type of
stent deployed during primary PCI. In this study patients with
high NT-proBNP levels had larger basal LV dimensions, low
LVEF, high LAVI and severe diastolic dysfunction, they also
showed progressive increase in their LV size with significant
reduction in LVEF during follow up. The 4 patients who
developed symptomatic heart failure had higher basal NT-
proBNP levels (mean ¼ 6698.75) compared to rest of thestudy group. The REVE-2 study,27 in contrast to the present
study, showed that baseline LVEF was the sole independent
predictor of LV remodeling but not basal NT-proBNP levels in
patients with AMI.
Results of previous studies on the association between NT-
proBNP levels and LV remodeling were conflicting, with some
studies showing a positive association like our study28e31 and
some showing no association.27,32 These conflicting observa-
tions may be related to heterogenous study populations,
retrospective study designs, or timing of blood sampling in
addition to problems related to sample size.
4.2. Left ventricular dyssynchrony in primary PCI
Left ventricular dyssynchrony is seen early in AMI even in the
absence of wide QRS complex or bundle branch block. The
degree of LV dyssynchrony is mainly determined by infarct
size.13 We observed higher LV dyssynchrony in patients with
anterior wall MI and those with higher Killips class at pre-
sentation. Severity of LV dyssynchrony in our study was not
significantly influenced by patient's age, window period,
Table 3 e Relationship of baseline echocardiographic data with study parameters on Univariate analysis.
Mean ± SD log NTproBNP levels LV dyssynchrony LAVI
Mean ± SD or r-value p-value Mean ± SD
or r-value
p-value Mean ± SD
or r-value
p-value
LVEDD (mm) 46.81 ± 4.59 0.065 0.44 0.021 0.802 0.317 <0.0001**
LVESD (mm) 34.15 ± 4.74 0.323 <0.0001** 0.253 0.002** 0.248 0.003**
LVEF% 50.84 ± 8.30 0.537 <0.0001** 0.467 <0.0001** 0.084 0.323
E velocity (cm/s) 72.65 ± 19.58 0.027 0.752 0.061 0.471 0.185 0.027*
A velocity (cm/s) 80.53 ± 19.05 0.057 0.498 0.040 0.637 0.053 0.531
E/A 0.96 ± 0.40 0.029 0.729 0.054 0.524 0.192 0.022*
E0 (cm/s) 6.40 ± 1.56 0.296 <0.0001** 0.087 0.303 0.019 0.822
E/E0 11.72 ± 3.40 0.271 0.001** 0.098 0.246 0.197 0.019*
LA volume (mL) 29.46 ± 7.99 0.023 0.790 0.020 0.816 e e
LAVI (mL/m2) 17.71 ± 4.41 0.172 0.041* 0.220 0.009** e e
LV dyssynchrony (ms) 55.79 ± 14.93 0.473 <0.0001** e e 0.220 0.009**
LVEDDI (mm/m2) 28.97 ± 8.50 0.261 0.002** 0.238 0.004* 0.418 <0.0001**
LVESDI (mm/m2) 21.2 ± 7.01 0.359 <0.0001** 0.340 <0.0001** 0.399 <0.0001**
Diastolic function:
Normal function to mild dysfunction 51 (35.9%) 6.79 ± 0.73 <0.0001** 55.61 ± 11.90 0.431 17.28 ± 4.91 0.613
Moderate dysfunction 62 (43.7%) 6.83 ± 0.96 54.50 ± 15.58 17.79 ± 3.65
Severe dysfunction 29 (20.4%) 7.56 ± 0.86 58.86 ± 18.11 18.29 ± 5.05
Systolic function:
Normal 85 (59.9%) 6.65 ± 0.82 <0.0001** 51.75 ± 12.29 <0.0001** 17.32 ± 4.19 0.425
Mild dysfunction 41 (28.9%) 7.32 ± 0.79 58.76 ± 15.02 18.20 ± 4.36
Moderate & severe dysfunction 16 (11.2%) 7.75 ± 0.87 69.62 ± 18.13 18.53 ± 5.67
LVEDD: left ventricular end diastolic diameter; LVESD: left ventricular end systolic diameter; LVEF: left ventricular ejection fraction; LVEDDI: left
ventricular end diastolic diameter index; LVESDI: left ventricular end systolic diameter index; LAVI: left atrial volume index.
Table 4 e Relationship of follow-up data with study parameters on Univariate analysis.
Mean ± SD/n (%) log NTproBNP levels LV dyssynchrony LAVI
Mean ± SD or r-value p-value Mean ± SD
or r-value
p-value Mean ± SD
or r-value
p-value
LVEDD (mm) 49.62 ± 4.63 0.321 <0.0001** 0.253 0.003** 0.296 <0.0001**
LVESD (mm) 34.78 ± 5.34 0.473 <0.0001** 0.350 <0.0001** 0.207 0.016**
LVEF% 54.73 ± 9.23 0.521 <0.0001** 0.398 <0.0001** 0.044 0.613
Change in LVEDD (mm):
Significant increase 43 (31.9%) 7.15 ± 0.81 0.061 59.02 ± 18.51 0.035* 17.39 ± 4.29 0.629
No significant change 92 (69.1%) 6.84 ± 0.92 53.52 ± 11.29 17.78 ± 4.31
Change in LVESD (mm):
Significant increase 37 (27.4%) 7.26 ± 0.96 0.008** 60.94 ± 18.53 0.004** 18.35 ± 4.49 0.246
No significant change 98 (72.6%) 6.81 ± 0.84 53.13 ± 11.52 17.39 ± 4.21
Change in LVEF%:
Significant decrease 10 (7.4%) 7.78 ± 0.96 0.004** 64.10 ± 14.37 0.004** 19.03 ± 4.74 0.386
No significant change 69 (51.1%) 6.80 ± 0.92 51.65 ± 11.39 17.23 ± 4.22
Significant increase 56 (41.5%) 6.95 ± 0.77 58.16 ± 15.98 17.93 ± 4.32
Diastolic function:
Normal to mild dysfunction 47 (34.8%) 6.53 ± 0.70 <0.0001** 53.59 ± 11.49 0.009** 17.39 ± 4.39 0.048*
Moderate dysfunction 70 (51.9%) 6.96 ± 0.85 53.97 ± 12.57 17.24 ± 4.08
Severe dysfunction 18 (13.3%) 7.89 ± 0.80 64.722 ± 21.75 19.96 ± 4.38
Systolic function:
Normal 104 (77.1%) 6.73 ± 0.83 <0.0001** 52.99 ± 13.34 0.002** 17.75 ± 4.33 0.502
Mild dysfunction 21 (15.6%) 7.44 ± 0.68 62.19 ± 14.66 16.75 ± 3.41
Moderate to severe dysfunction 10 (7.3%) 8.01 ± 0.75 64.50 ± 14.35 18.53 ± 5.57
LVEDD: left ventricular end diastolic diameter; LVESD: left ventricular end systolic diameter; LVEF: left ventricular ejection fraction.
*indicates p < 0.05; **indicates p < 0.01.
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Fig. 3 e Comparison of NT-proBNP, LA volume and LV dyssynchrony in patients with increase in LVEDD and no change in
LVEDD.
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 3 1 8e3 2 7 325number of vessels involved, whether infarct related coronary
artery totally occluded or not, thrombus aspiration and
administration of GP 2b/3a inhibitors during primary PCI.
Patients with culprit lesion in RCA showed lesser LV dys-
synchrony compared to patients with lesions in LAD and LCX
(p ¼ 0.023). But in a study by Ng et al11 patients with proximal
LCX stenosis had higher LV dyssynchrony and no significant
difference between patients with lesions in LAD and RCA.
In our study, LV dyssynchrony was higher in patients with
low baseline LVEF which was also seen in a previous study by
Nucifora et al10 and we also observed that these patients had
significant increase in their LV dimensions with decrease in
LVEF and severe diastolic dysfunction at 6 months follow up.
Numerous reports have been published on LV dyssyn-
chrony mainly in relation to prediction of response to cardiac
resynchronization therapy. In the present study a significant
degree of LV dyssynchrony is predictive of LV remodeling.
This may offer a possibility to identify patients at risk for LVTable 5 e Multivariate analysis.
B S.E p-val Exp(B)
LAVI 0.048 0.078 0.540 0.953
LV dyssynchrony 0.006 0.023 0.781 0.994
log NTproBNP 1.139 0.461 0.013 0.320
Baseline LVEF 0.008 0.016 0.623 0.104
LVEDD 0.110 0.035 0.241 0.829
LVESD 0.134 0.045 0.411 0.532
Dependent variable: change in LVEF.remodeling early after infarction and to subsequently inten-
sify treatment of these patients.4.3. Left atrial volume index in primary PCI
The Doppler variables of LV diastolic function are affected by
acute hemodynamic changes, but LAVI is a more stable
parameter, integrating the effects of elevated LV filling pres-
sures from pre-existing cardiovascular conditions as well as
acute disease.33 In the present study, LAVI showed significant
correlation with baseline LV dimensions and diastolic func-
tion, but not with baseline LV systolic function. Patient's with
higher baseline LAVI had severe diastolic dysfunction at 6
months follow up but could not predict increase in LV di-
mensions and decrease in LVEF at 6 months follow up.
Contrary to our findings, previous studies15,34,35 reported
prognostic role of LAVI in predicting survival and heart failure
in patients with MI during follow up. In these studies patients
were older, did not undergo revascularization, had higher
baseline LAVI, followed up for longer time period (20
monthse5 years) and only clinical events were noted without
assessment of LV remodeling.
In a recent study by Lonborg et al36 in patients with STEMI
observed that maximal LA volume had no significant role in
predicting MACE, but LA fractional change and LA minimal
volume could better predict cardiovascular events in these
patients.
In our study 3 patients died during follow up, of whom one
patient died due to CHF and the other 2 patients who experi-
enced sudden cardiac death may be due to probable stent
thrombosis. Because of low mortality in our study it was not
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 3 1 8e3 2 7326possible to define the prognostic information of NT-proBNP
levels, LV dyssynchrony and LAVI on survival rate.
Binary logistic regression analysis showed that LV dys-
synchrony and log NT-proBNP as independent predictors for
increase in LVSED after 6 months and only NT-proBNP for
decrease in LVEF.
4.4. Limitations
The main limitation of our study was relatively small sample
size with 142 patients and short duration of follow up. As TDI
is angle dependent, it cannot exclude the influence of motion
of entire heart and “tethering” movement of adjacent seg-
ments. In this study patients with prior coronary artery
bypass grafting, history of previous MI, very old age, presence
of atrial fibrillation, pre existing bundle branch block and pa-
tients with renal failure were excluded. This may introduce
the risk of selection bias on prognostic value of NT-proBNP,
LAVI and LV dyssynchrony. Left ventricular mass was not
assessed in this study, which could influence the NT-proBNP
levels and LAVI. Left ventricular volumes were not assessed
at base line and during follow up. Only LV size was assessed.
In the present study echocardiographic parameters were
assessedwithin 48 h after primary PCI not at a fixed time point
in all patients. This may have impact in the assessment of LV
diastolic, systolic function and LV dyssynchrony as these pa-
rameters are likely to be greatly altered by changes in LV
contractile function resulting from early reperfusion.5. Conclusions
In patients with AMI, higher basal NT-proBNP levels can pre-
dict progressive increase in LV size, worsening of LV systolic,
diastolic function and occurrence of CHF during follow-up.
Higher LV dyssynchrony at baseline can predict patients
with increase in LV size and deterioration of LV systolic and
diastolic functions during follow up. It has incremental prog-
nostic value to NT-proBNP levels in predicting increase in LV
size during follow up.Conflicts of interest
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